Computational investigations of hERG channel blockers: New insights and current predictive models

Advanced Drug Delivery Reviews
Bruno O Villoutreix, Olivier Taboureau

Abstract

Identification of potential human Ether-a-go-go Related-Gene (hERG) potassium channel blockers is an essential part of the drug development and drug safety process in pharmaceutical industries or academic drug discovery centers, as they may lead to drug-induced QT prolongation, arrhythmia and Torsade de Pointes. Recent reports also suggest starting to address such issues at the hit selection stage. In order to prioritize molecules during the early drug discovery phase and to reduce the risk of drug attrition due to cardiotoxicity during pre-clinical and clinical stages, computational approaches have been developed to predict the potential hERG blockage of new drug candidates. In this review, we will describe the current in silico methods developed and applied to predict and to understand the mechanism of actions of hERG blockers, including ligand-based and structure-based approaches. We then discuss ongoing research on other ion channels and hERG polymorphism susceptible to be involved in LQTS and how systemic approaches can help in the drug safety decision.

References

Jul 17, 1999·Pharmaceutical Science & Technology Today·W Crumb, I Cavero
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·J S MitchesonM C Sanguinetti
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Sean EkinsSteven A Wrighton
May 31, 2002·Nature·Youxing JiangRoderick MacKinnon
May 2, 2003·Nature·Youxing JiangRoderick MacKinnon
May 29, 2003·The Journal of General Physiology·Jixin WangPaul B Bennett
May 31, 2003·Nature Reviews. Drug Discovery·Bernard Fermini, Anthony A Fossa
Jul 23, 2003·Bioorganic & Medicinal Chemistry Letters·György M Keserü
Feb 21, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·C W YapY Z Chen
Apr 15, 2004·Bioorganic & Medicinal Chemistry·Alex M Aronov, Brian B Goldman
Apr 28, 2004·Drug Discovery Today·Claire WoodGareth J Waldron
Apr 28, 2004·Cell Calcium·A M Brown
Jun 24, 2004·Molecular Pharmacology·Eckhard FickerArthur M Brown
Aug 4, 2004·Progress in Biophysics and Molecular Biology·William BainsCat White
Jan 27, 2005·SAR and QSAR in Environmental Research·A O Aptula, M T D Cronin
Feb 18, 2005·Journal of Medicinal Chemistry·Sean E O'Brien, Marcel J de Groot
Mar 5, 2005·Bioorganic & Medicinal Chemistry Letters·Ramkumar RajamaniCharles H Reynolds
May 25, 2005·Bioorganic & Medicinal Chemistry Letters·Motoi TobitaRenpei Nagashima
Jun 14, 2005·Journal of Pharmacological and Toxicological Methods·Barbara A WibleArthur M Brown
Jun 28, 2005·Bioorganic & Medicinal Chemistry Letters·Giovanni CianchettaRoy J Vaz
Nov 18, 2005·Journal of Pharmacological and Toxicological Methods·Peter Hoffmann, Barbara Warner
Dec 6, 2005·Biochemical Pharmacology·Zhi SuGary A Gintant
Jan 24, 2006·Journal of Chemical Information and Modeling·Minghu Song, Matthew Clark
Jan 24, 2006·Bioorganic & Medicinal Chemistry·Alessio CoiAnna Maria Bianucci
Mar 2, 2006·Toxicologic Pathology·Gary A GintantBryan F Cox
Apr 18, 2006·Bioorganic & Medicinal Chemistry·Michael M Gepp, Michael C Hutter
Apr 25, 2006·Chemical Biology & Drug Design·Mark Seierstad, Dimitris K Agrafiotis
May 23, 2006·Journal of Chemical Information and Modeling·Katsumi Yoshida, Tomoko Niwa
Nov 28, 2006·Journal of Chemical Information and Modeling·S BhavaniN Chandra
Dec 13, 2006·Journal of Medicinal Chemistry·Alex M Aronov
Jan 24, 2007·Bioorganic & Medicinal Chemistry Letters·Michael J Waring, Craig Johnstone
Feb 9, 2007·Nature Biotechnology·Michael J KeiserBrian K Shoichet
Feb 15, 2007·Expert Opinion on Therapeutic Targets·Harry J Witchel
Mar 27, 2007·Journal of Computer-aided Molecular Design·Claire L GavaghanScott Boyer
Apr 21, 2007·Proteins·Phillip J StansfeldMichael J Sutcliffe
Jul 3, 2007·Journal of Chemical Information and Modeling·Olga ObrezanovaMatthew D Segall
Oct 12, 2007·Journal of Molecular Graphics & Modelling·Divita GargC Gopi Mohan

❮ Previous
Next ❯

Citations

Jan 1, 2016·Journal of Chemical Information and Modeling·Patric SchymanAnders Wallqvist
Dec 18, 2015·Archives of Toxicology·Xichun LiZhengyu Cao
Apr 14, 2016·Toxicology Letters·Marco GobbiMario Salmona
Jul 28, 2016·Expert Opinion on Drug Discovery·Sunghwan Kim
Oct 27, 2016·Journal of Computer-aided Molecular Design·Remigijus Didziapetris, Kiril Lanevskij
Dec 22, 2016·Molecular Informatics·Hongmao SunYuhong Wang
Feb 22, 2017·Molecular Informatics·Maria A Miteva, Bruno O Villoutreix
May 4, 2017·Medicinal Research Reviews·Subha Kalyaanamoorthy, Khaled H Barakat
Jul 7, 2018·PloS One·Tomohiro SatoTeruki Honma
Mar 19, 2020·Briefings in Bioinformatics·Natesh SinghBruno O Villoutreix
Feb 6, 2020·Bioinformatics·Jae Yong RyuKwang-Seok Oh
Dec 15, 2017·Expert Opinion on Drug Discovery·Subha Kalyaanamoorthy, Khaled H Barakat
May 30, 2017·Archives of Toxicology·Svetoslav SlavovRichard Beger
Feb 11, 2020·Frontiers in Pharmacology·Andrew ButlerChristopher E Dempsey
Jan 30, 2021·Computational and Structural Biotechnology Journal·Eitan MargulisMasha Y Niv
Jan 14, 2020·Journal of Medicinal Chemistry·Ziyi YangDongsheng Cao
Mar 2, 2021·Experimental Biology and Medicine·Siyu ZhuJing An
Sep 6, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Pavlo V ZadorozhniiAleksandr V Kharchenko
Nov 28, 2020·Journal of Chemical Information and Modeling·Hans MatterGerhard Hessler
Feb 5, 2019·Journal of Chemical Information and Modeling·Chuipu CaiFeixiong Cheng
Sep 11, 2021·Journal of Chemical Information and Modeling·Teresa Maria CreanzaGiuseppe Felice Mangiatordi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.